Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, 'cauliflower-like' surface appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed, and it is recommended to soak the wart in warm water for approximately 5 minutes. Following this, the area must be dried thoroughly to ensure proper adhesion of the medicated patch.

If necessary, the medicated patch may be cut to fit the size of the wart. The patch should then be applied with the adhesive side facing down directly onto the wart. To ensure the patch remains in place and to conceal the area, it should be covered with a pad.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application is not recommended on irritated, infected, or reddened skin due to the potential for exacerbating these conditions. The product should not be applied to genital warts or warts located on the face, as these areas may have increased sensitivity and risk of adverse reactions. Additionally, the use is contraindicated on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that require different management. The product must not be used on mucous membranes, as this could lead to irritation or other complications.

Warnings and Precautions

For external use only. This product is contraindicated for application on irritated, infected, or reddened skin. It should not be used on genital warts, warts located on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it is not intended for use on mucous membranes.

Healthcare professionals should advise patients to consult a physician prior to use if they have diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Patients should be instructed to discontinue use and seek medical advice if discomfort persists.

It is essential to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients should be aware that the product is intended for external use only. It is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, and warts with hair growing from them. Additionally, the product should not be used on mucous membranes.

Before using the product, patients with diabetes or poor blood circulation are advised to consult a healthcare professional. If discomfort persists after application, patients should discontinue use and seek medical advice.

It is crucial to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been established. There are no available data regarding the potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to discuss the potential risks and benefits with their patients. It is recommended that healthcare providers remain vigilant and informed about any emerging data related to the use of this medication in pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use the medication on irritated, infected, or reddened skin, as well as on genital warts and warts located on the face. It is also important to inform patients that the medication should not be applied to moles, birthmarks, or warts with hair growing from them, nor should it be used on mucous membranes.

Healthcare providers should counsel patients to discontinue use and consult a doctor if discomfort persists. Additionally, patients with diabetes or poor blood circulation should be advised to consult a doctor before using the medication to ensure safety and appropriateness of treatment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 59°F to 86°F (15°C to 30°C) to maintain its efficacy and stability. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)